Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Sales | 406,164 | 358,756 | 355,880 | 336,922 | 329,574 |
| Cost of Goods | 178,343 | 142,331 | 154,376 | 149,601 | 154,185 |
| Gross Profit | 227,821 | 216,425 | 201,504 | 187,321 | 175,389 |
| Operating Expenses | 138,428 | 132,126 | 116,076 | 109,179 | 99,403 |
| Operating Income | 89,736 | 84,630 | 85,804 | 78,743 | 76,171 |
| Interest Expense | 6,907 | 5,980 | 7,580 | 5,341 | 5,391 |
| Other Income | -985 | 2,133 | 1,393 | 1,681 | -2,371 |
| Pre-tax Income | 81,844 | 80,783 | 79,617 | 75,083 | 68,409 |
| Income Tax | 29,768 | 29,324 | 28,902 | 27,254 | 25,311 |
| Net Income Continuous | 52,076 | 51,459 | 50,715 | 47,829 | 43,098 |
| Net Income | $52,076 | $51,459 | $50,715 | $47,829 | $43,098 |
| EPS Basic Total Ops | 0.48 | 0.48 | 0.47 | 0.45 | 0.41 |
| EPS Basic Continuous Ops | 0.48 | 0.48 | 0.47 | 0.45 | 0.40 |
| EPS Diluted Total Ops | 0.36 | 0.47 | 0.47 | 0.44 | 0.40 |
| EPS Diluted Continuous Ops | 0.29 | 0.47 | 0.47 | 0.44 | 0.40 |
| EBITDA(a) | $115,365 | $109,366 | $110,430 | $104,104 | $99,835 |